register

Medical and Science

Aussie experts sign WHO’s COVID-19 vaccine pledge

Health Industry Hub | April 15, 2020 |

Medical News: As part of World Health Organisation’s (WHO) response to the COVID-19 outbreak, a Research and Development (R&D) Blueprint has been activated to accelerate the development of diagnostics, vaccines and therapeutics for this novel coronavirus.

Australian researchers working on COVID-19 vaccines have signed a WHO declaration pledging global collaboration to develop a COVID-19 vaccine. The statement applauds the community intervention measures that have taken place, with scientist pledging to use the time gained by the implementation of these measures to develop a vaccine as rapidly as possible. The pledge promises to strengthen the unprecedented worldwide collaboration, cooperation and sharing of data already underway.

Declaration

“We are scientists, physicians, funders and manufacturers who have come together as part of an international collaboration, coordinated by the World Health Organisation (WHO), to help speed the availability of a vaccine against COVID-19. While a vaccine for general use takes time to develop, a vaccine may ultimately be instrumental in controlling this worldwide pandemic. In the interim, we applaud the implementation of community intervention measures that reduce spread of the virus and protect people, including vulnerable populations, and pledge to use the time gained by the widespread adoption of such measures to develop a vaccine as rapidly as possible. We will continue efforts to strengthen the unprecedented worldwide collaboration, cooperation and sharing of data already underway. We believe these efforts will help reduce inefficiencies and duplication of effort, and we will work tenaciously to increase the likelihood that one or more safe and effective vaccines will soon be made available to all.”

Australian Experts in Worldwide Collaboration

  • Keith Chappell, University of Queensland        
  • Damian Purcell, Doherty Institute for Infection and Immunity
  • Paul R Young, University of Queensland

Register FREE and join 20,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

You may also like Customer-Centric Engagement During COVID-19


Digital & Innovation

Health Minister blasts decade of digital neglect in healthcare

Health Minister blasts decade of digital neglect in healthcare

Health Industry Hub | October 18, 2024 |

Minister for Health and Aged Care, Mark Butler, has laid out the government’s plans for a digital overhaul of the […]

More


News & Trends - Pharmaceuticals

Novartis challenges hospitals over copycat cancer treatment, fuelling debate on access

Novartis challenges hospitals over copycat cancer treatment, fuelling debate on access

Health Industry Hub | October 18, 2024 |

Pharma News: Novartis is urging Australian hospitals to halt the production of copycat alternatives to its radioligand therapy, Pluvicto. The […]

More


News & Trends - MedTech & Diagnostics

A boost to the nation's medtech footprint with strategic US partnership

A boost to the nation’s medtech footprint with strategic US partnership

Health Industry Hub | October 18, 2024 |

MedTech & Diagnostics News: Minnesota has been a centre of health innovation for decades. The state houses the #1 hospital […]

More


News & Trends - Pharmaceuticals

Calls grow to address glaring gaps for cancer-induced menopause sufferers: World Menopause Day

Calls grow to address glaring gaps in cancer-induced menopause: World Menopause Day

Health Industry Hub | October 18, 2024 |

Marking World Menopause Day on October 18, several organisations are drawing attention to the urgent need for enhanced support and […]

More


This content is copyright protected. Please subscribe to gain access.